Home LiteratureArticle Details
PMID: 12668917 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations.

Pharmacogenetics ·Vol. 13 ·No. 4 ·2003-04-00 ·Pages 207-18

Rogan PK, Svojanovsky S, Leeder JS

Abstract

Several mutations are known or suspected to affect mRNA splicing of CYP2C19, CYP2D6 and CYP3A5 genes; however, little experimental evidence exists to support these conclusions. The present study applies mathematical models that measure changes in information content of splice sites in these genes to demonstrate the relationship between the predicted phenotypes of these variants to the corresponding genotypes. Based on information analysis, the CYP2C19*2 variant activates a new cryptic site 40 nucleotides downstream of the natural splice site. CYP2C19*7 abolishes splicing at the exon 5 donor site. The CYP2D6*4 allele similarly inactivates splicing at the acceptor site of exon 4 and activates a new cryptic site one nucleotide downstream of the natural acceptor. CYP2D6*11 inactivates the acceptor site of exon 2. The CYP3A5*3 allele activates a new cryptic site 236 nucleotides upstream of the exon 4 natural acceptor site. CYP3A5*5 inactivates the exon 5 donor site and CYP3A5*6 strengthens a site upstream of the natural donor site, resulting in skipping of exon 7. Other previously described missense and nonsense mutations at terminal codons of exons in these genes affected splicing. CYP2D6*8 and CYP2D6*14 both decrease the strength of the exon 3 donor site, producing transcripts lacking this exon. The results of information analysis are consistent with the poor metabolizer phenotypes observed in patients with these mutations, and illustrate the potential value of these mathematical models to quantitatively evaluate the functional consequences of new mutations suspected of altering mRNA splicing.

MeSH Terms
Amino Acid Substitution Base Sequence Binding Sites Cytochrome P-450 CYP2D6/genetics Cytochrome P-450 CYP3A Cytochrome P-450 Enzyme System/genetics Databases, Protein Exons Genetic Variation Introns Models, Theoretical Molecular Sequence Data Mutagenesis, Site-Directed Mutation, Missense RNA Interference RNA, Messenger/genetics
Chemicals
RNA, Messenger Cytochrome P-450 Enzyme System CYP3A protein, human CYP3A5 protein, human Cytochrome P-450 CYP2D6 Cytochrome P-450 CYP3A
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rogan Peter K
Laboratory of Human Molecular Genetics, Children's Mercy Hospital and Clinics, Kansas City, Missouri 64108, USA. [email protected]
Svojanovsky Stan
Leeder J Steven
Article Info
Journal
Pharmacogenetics
Abbr.
Pharmacogenetics
ISSN
0960-314X
Published
2003-04-00
Pages
207-18
Language
English
Region
England
NLM ID
9211735
Subset
IM
Grants
NIEHS NIH HHS · ES10855 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]